Comparative Trial of the Pharmacokinetics and Pharmacodynamics of Intramuscularly Injected CinnoVex and Avonex in Healthy Volunteers
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors CinnaGen
- 08 Jan 2020 Status changed from recruiting to completed.
- 08 Aug 2018 New trial record